Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter ended in March - Earnings Summary

Reviva Pharmaceuticals Holdings

15/05/2023 22:35

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ  reported a
quarterly adjusted loss of 30 cents​​ per share for the quarter
ended in March. The mean expectation of two analysts for the
quarter was for a loss of 32 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Reviva Pharmaceuticals Holdings, Inc.'s reported EPS for
the
quarter was a loss of 30 cents​.
    * The mean earnings estimate of analysts had fallen by
about 38.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Reviva Pharmaceuticals Holdings, Inc. shares had risen
by 75.2%
this quarter and gained 72.7% so far this year.
    * The company reported a quarterly loss of $6.6 million.
    * Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 09:35 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.32          -0.30          Beat
 Dec. 31 2022      -0.22          -0.38          Missed
 Sep. 30 2022      -0.29          -0.18          Beat
 Jun. 30 2022      -0.35          -0.29          Beat